These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
580 related items for PubMed ID: 2704109
1. The role of data audits in detecting scientific misconduct. Results of the FDA program. Shapiro MF, Charrow RP. JAMA; 1989 May 05; 261(17):2505-11. PubMed ID: 2704109 [Abstract] [Full Text] [Related]
2. The role of data audits in detecting scientific misconduct. JAMA; 1990 Jul 04; 264(1):35-8. PubMed ID: 2192092 [No Abstract] [Full Text] [Related]
3. Scientific misconduct in investigational drug trials. Shapiro MF, Charrow RP. N Engl J Med; 1985 Mar 14; 312(11):731-6. PubMed ID: 3974649 [No Abstract] [Full Text] [Related]
4. Research misconduct identified by the US Food and Drug Administration: out of sight, out of mind, out of the peer-reviewed literature. Seife C. JAMA Intern Med; 2015 Apr 14; 175(4):567-77. PubMed ID: 25664866 [Abstract] [Full Text] [Related]
5. Data audit by a regulatory agency: its effect and implication for others. Shapiro MF. Account Res; 1992 Apr 14; 2(3):219-29. PubMed ID: 11653981 [No Abstract] [Full Text] [Related]
6. American Society of Clinical Oncology policy statement: oversight of clinical research. American Society of Clinical Oncology. J Clin Oncol; 2003 Jun 15; 21(12):2377-86. PubMed ID: 12721281 [Abstract] [Full Text] [Related]
7. Protecting human research subjects and the public: the role of FDA disqualification of clinical investigators. Nightingale SL. Food Drug Cosmet Law J; 1980 Sep 15; 35(9):484-92. PubMed ID: 11661914 [No Abstract] [Full Text] [Related]
8. Responding to scientific misconduct. Due process and prevention. Mishkin B. JAMA; 1988 Oct 07; 260(13):1932-6. PubMed ID: 3418855 [Abstract] [Full Text] [Related]
11. A view of misconduct in science. Racker E. Nature; 1989 May 11; 339(6220):91-3. PubMed ID: 2716839 [Abstract] [Full Text] [Related]
12. Science needs vigilance not vigilantes. Woolf PK. JAMA; 1988 Oct 07; 260(13):1939-40. PubMed ID: 3418857 [Abstract] [Full Text] [Related]
13. A study of warning letters issued to clinical investigators by the United States Food and Drug Administration. Bramstedt KA. Clin Invest Med; 2004 Jun 07; 27(3):129-34. PubMed ID: 15305804 [Abstract] [Full Text] [Related]
14. Raising suspicions with the Food and Drug Administration: detecting misconduct. Hamrell MR. Sci Eng Ethics; 2010 Dec 07; 16(4):697-704. PubMed ID: 20842536 [Abstract] [Full Text] [Related]
15. Fraud, errors taint a key study of widely used Sanofi drug; despite some faked results, FDA approves antibiotic; one doctor's cocaine use; company defends safety. Mathews AW. Wall St J (East Ed); 2006 May 01; ():A1, A12. PubMed ID: 16838449 [No Abstract] [Full Text] [Related]
16. Policing fraud and deceit: the legal aspects of misconduct in scientific inquiry. Protti M. J Infor Ethics; 1996 May 01; 5(1):59-71. PubMed ID: 11653390 [No Abstract] [Full Text] [Related]
17. Science and law clash over fraud-case appeals. Hilts PJ. N Y Times Web; 1993 Nov 08; ():B10. PubMed ID: 11647010 [No Abstract] [Full Text] [Related]
18. A Retrospective Analysis of Clinical Research Misconduct Using FDA-Issued Warning Letters and Clinical Investigator Inspection List From 2010 to 2014. Romano CA, Nair S, Delphin ES. Anesth Analg; 2018 Mar 08; 126(3):976-982. PubMed ID: 29239950 [Abstract] [Full Text] [Related]
19. Criminal liability for misconduct in scientific research. Kuzma SM. Univ Mich J Law Reform; 1992 Mar 08; 25(2):357-421. PubMed ID: 11651584 [No Abstract] [Full Text] [Related]
20. From Baltimore to Bell Labs: reflections on two decades of debate about scientific misconduct. Resnik DB. Account Res; 2003 Mar 08; 10(2):123-35. PubMed ID: 14577424 [Abstract] [Full Text] [Related] Page: [Next] [New Search]